Fundraising FoxMacrolide Pharmaceuticals
Watertown, US · Founded 2014 · Delaware corporation · 4 known investors
Find your way into Macrolide Pharmaceuticals
Sign up to see every warm intro you have to Macrolide Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Macrolide Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EM
Edward MascioliExecutive
AM
Andrew MyersNamed on SEC filing
Board
MG
Markus GoebelBoard director
HS
VG
Vikas GoyalBoard director
RP
AH
CV
Christopher ViehbacherBoard director
JZ
Joseph ZakrzewskiBoard director
MS
Mary SzelaBoard director
Investors · 4
Advent Life SciencesreportedLondonvia Raj Parekh · board
How we know: board seat on SEC Form D · funding news · press coverage · Not right? Tell us
Gurnet Point Capitalreported
How we know: funding news · press coverage · Not right? Tell us
Novartis Venture FundreportedBasel · $5M – $25M
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$31.7M disclosed across 3 rounds · 2015–2020
▶$7.5MraisedApr 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedApr 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sumit AggarwalExecutive Officer, Director
- Christopher A. ViehbacherDirector
- Raj B. Parekh, Ph.D.Director
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedMar 2018 · 6 investors · PharmaceuticalsRule 506(b)
▶$12MraisedMar 2018 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Markus GoebelDirector
- Christopher ViehbacherDirector
- Joseph ZakrzewskiDirector
- Henry SkinnerDirector
- Mary SzelaDirector
- Vikas GoyalDirector
- Raj ParekhDirector
- Andrew MyersDirector
- Anja HarmeierDirector
- Edward MascioliExecutive Officer
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$12.2MraisedApr 2016 · 10 investors · PharmaceuticalsRule 506(b)
▶$12.2MraisedApr 2016 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew LittlehaleExecutive Officer
- Henry SkinnerDirector
- Monique SciersingDirector
- Raj ParekhDirector
- Andrew G. MyersDirector
- Lawrence MillerExecutive Officer, Director
- Vikas GoyalDirector
- Fereydoun FirouzDirector
- Offering amount
- $27.8M
- Amount sold
- $12.2M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Macrolide Pharmaceuticals's investors?
- Macrolide Pharmaceuticals's investors include Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Venture Fund.
- How much funding has Macrolide Pharmaceuticals raised?
- Macrolide Pharmaceuticals has disclosed $31.7M raised across 3 rounds.
- Where is Macrolide Pharmaceuticals headquartered?
- Macrolide Pharmaceuticals is headquartered in Watertown, US.